What is the treatment for anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Anaphylaxis

The first-line treatment for anaphylaxis is immediate administration of epinephrine via intramuscular injection in the mid-outer thigh (vastus lateralis muscle) as soon as anaphylaxis is recognized. 1, 2

Immediate Management Algorithm

  1. Recognition and Initial Response

    • Recognize anaphylaxis symptoms: skin manifestations (hives, swelling), respiratory symptoms (difficulty breathing, wheezing), cardiovascular symptoms (hypotension, tachycardia), and/or gastrointestinal symptoms (vomiting, abdominal pain) 1
    • Call for emergency assistance (911/EMS) 3
    • Position patient appropriately: recumbent with legs elevated if hypotensive 1
  2. Epinephrine Administration

    • Dosing:
      • Adults and children ≥30 kg: 0.3-0.5 mg (0.3-0.5 mL of 1:1000 concentration) 1, 3
      • Children <30 kg: 0.01 mg/kg, maximum 0.3 mg (0.01 mL/kg of 1:1000 concentration) 1, 3
    • Route: Intramuscular injection in the mid-outer thigh (vastus lateralis) 1
    • Timing: Repeat every 5-15 minutes if symptoms persist or worsen 1
  3. Airway Management

    • Establish and maintain airway 1
    • Administer oxygen at 6-8 L/min 1
    • Monitor for signs of airway compromise; endotracheal intubation may be necessary in severe cases 1
  4. Fluid Resuscitation

    • Establish intravenous access 1
    • Administer normal saline for fluid replacement (1-2 L may be required for adults) 1

Secondary Interventions

After epinephrine administration, consider the following adjunctive therapies:

  1. Antihistamines

    • H1 antagonists (e.g., diphenhydramine 25-50 mg IV/IM) for cutaneous symptoms 3
    • H2 antagonists (e.g., ranitidine 50 mg IV or famotidine 20 mg IV) may be added 3
  2. Bronchodilators

    • Albuterol 2.5-5 mg via nebulizer for persistent bronchospasm 3
  3. Corticosteroids

    • Methylprednisolone 1-2 mg/kg IV or prednisone 0.5 mg/kg orally to potentially prevent biphasic reactions 3
  4. Vasopressors

    • For refractory hypotension, consider dopamine (2-20 μg/kg/min) titrated to maintain systolic BP >90 mmHg 1

Monitoring and Follow-up

  • Monitor vital signs continuously, including blood pressure, heart rate, and oxygen saturation 3
  • Observe patients for at least 4-6 hours after symptom resolution due to risk of biphasic reactions 3
  • High-risk patients (severe initial reaction, requiring multiple epinephrine doses) may need extended observation (≥6 hours) or hospital admission 3

Important Considerations and Pitfalls

  • Delayed epinephrine administration is associated with increased mortality. Never delay giving epinephrine while administering secondary medications. 1, 4

  • Route matters: Intramuscular injection in the thigh produces higher and more rapid peak plasma levels compared to subcutaneous or arm injections. 1, 5

  • Epinephrine autoinjectors (e.g., EpiPen) can be used through clothing into the lateral thigh for rapid administration. 1

  • Biphasic reactions can occur in up to 20% of cases, with symptoms recurring hours after initial resolution without re-exposure to the trigger. 6

  • Avoid standing or walking during acute anaphylaxis as this can worsen hypotension and accelerate vascular collapse. 1

  • No absolute contraindications exist for epinephrine use in anaphylaxis, even in patients with cardiovascular disease. The benefits outweigh the risks. 1

  • Patient education is essential, including prescription of epinephrine autoinjectors (typically 2), training on their use, and development of an emergency action plan. 7, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Angioedema Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine in the Management of Anaphylaxis.

The journal of allergy and clinical immunology. In practice, 2020

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Research

Anaphylaxis: Recognition and Management.

American family physician, 2020

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Research

Allergy and Asthma: Anaphylaxis.

FP essentials, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.